Cargando…
Reduced RANBP9 expression is associated with poor prognosis in colorectal cancer patients
BACKGROUND: Colorectal cancer (CRC) is the third most common malignancy worldwide. RANBP9 is a RAN-binding protein that has been reported to be a reliable predictor for prognosis in some human cancers. The mechanism of RANBP9 involvement in CRC carcinogenesis is unknown. This study measured RANBP9 e...
Autores principales: | Wu, Guangbin, Li, Ji, Qin, Chunzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797687/ https://www.ncbi.nlm.nih.gov/pubmed/35117028 http://dx.doi.org/10.21037/tcr.2019.10.24 |
Ejemplares similares
-
RANBP9 suppresses tumor proliferation in colorectal cancer
por: Qin, Chunzhi, et al.
Publicado: (2019) -
RanBP9 at the intersection between cofilin and Aβ pathologies: rescue of neurodegenerative changes by RanBP9 reduction
por: Woo, J A, et al.
Publicado: (2015) -
Downregulation of circ-RANBP9 in laryngeal cancer and its clinical significance
por: Wang, Zheng, et al.
Publicado: (2021) -
RANBP9 as potential therapeutic target in non-small cell lung cancer
por: Tessari, Anna, et al.
Publicado: (2020) -
Association of tricellulin expression with poor colorectal cancer prognosis and metastasis
por: Zhang, Jin-Xiu, et al.
Publicado: (2020)